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416Objective: The study objective was to determine whether significant trends over time have occurred in resource
use associated with the use of extracorporeal membrane oxygenation in critically ill adults.
Methods: All adult admissions involving extracorporeal membrane oxygenation were examined by using the
Nationwide Inpatient Sample database (years 1998-2009). Trends in volume, outcome, and resource use
(including hospital charges, length of stay, and charges per day) were analyzed.
Results: An estimated total of 8753 admissions involved extracorporeal membrane oxygenation over the study
period. Overall length of stay was 18.3  1.3 days. Total hospital charges averaged $344,009  $30,707 per
admission, with average charges per day of $40,588  $3099. Cumulative national charges for extracorporeal
membrane oxygenation admissions increased significantly from $109.0 million in 1998 to $764.7 million in
2009 (P ¼ .0016). Charges per patient and length of stay also increased significantly (P ¼ .0032 and .0321,
respectively). The increasing trend in the number of extracorporeal membrane oxygenation admissions during
the study period was not statistically significant (P ¼ .19). The post-cardiotomy group had more favorable out-
comes and lower resource use. A shift was observed in the relative case-mix of extracorporeal membrane
oxygenation admissions over the study period, with a relative decrease in the post-cardiotomy group and
increases in the cardiogenic shock, respiratory failure, and lung transplant groups.
Conclusions: These results suggest that dramatic increases in resource use associated with extracorporeal mem-
brane oxygenation are not solely the result of increased volume, but in part are due to a shift toward extracor-
poreal membrane oxygenation use in patient groups (other than in the post-cardiotomy setting) with greater
resource use and worse outcomes. (J Thorac Cardiovasc Surg 2014;148:416-21)Supplemental material is available online.
Extracorporeal membrane oxygenation (ECMO) is a well-
established but complex and resource-intensive life-
support intervention for critically ill patients with cardiac
or respiratory failure.1 ECMO therapy in adults was first
used in 1972 in a case of acute post-traumatic respiratory
failure.2 Since that time, ECMO expanded to a wide-
range of life-support indications. Although adult patients
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registry, they are a rapidly growing group.3
Single institution reports and those including only the
neonatal population have described the costs4,5 and cost-
benefit or cost-effectiveness analyses6,7 of ECMO, but
multi-institutional studies on the use of ECMO in adults
are lacking.8 More focused economic analyses9,10 have
not provided information on trends over time in the
resource use associated with ECMO use in adults.
We used an established, nationally representative admin-
istrative database to examine trends in resource use mea-
sures and in-hospital mortality in adults undergoing
ECMO from 1998 to 2009, to test the hypothesis that
changes in the numbers and makeup of this population
have caused significant shifts in ECMO-associated resource
use.MATERIALS AND METHODS
The Stanford University Institutional Review Board granted an exemp-
tion from review because this research uses de-identified data. Administra-
tive records were extracted from discharge datasets for the years 1998 to
2009 from the Nationwide Inpatient Sample (NIS), Healthcare Cost and
Utilization Project, Agency for Healthcare Research and Quality. The
NIS is the largest publicly available all-payer database for inpatient care
in the United States. Each dataset year includes records on 7 to 8 million
admissions from approximately 1000 hospitals in 44 states, which reflectery c August 2014
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Da 20% stratified sample of all US nonfederal, nonrehabilitation hospitals.11
It contains discharge sample weights to facilitate nationally representative
estimates based on the sampling design. Although it contains limited,
administrative data on each inpatient encounter, its size and sampling
frame facilitates the analysis of comparatively rare clinical events at a na-
tional level.
Healthcare Cost and Utilization Project–supplied Clinical Classifica-
tions Software for the International Classification of Diseases, 9th Revi-
sion, Clinical Modification (ICD-9-CM) was used to generate diagnostic,
comorbidity, and procedural classification codes. ECMO use was estab-
lished using ICD-9-CM Volume 3 procedure codes 39.65 (extracorporeal
membrane oxygenation) and 39.66 (percutaneous extracorporeal mem-
brane oxygenation). These codes are explicitly exclusive of codes for car-
diopulmonary bypass (used in the operating room for cardiac surgery) and
hemodialysis. All adult (age18 years) admission records with an ECMO
procedure code recorded were identified and sorted into 1 of 7 predefined
groups, based on prior internal reviews and existing literature documenting
categories of indications for ECMO use in adults: post-cardiotomy circula-
tory or respiratory failure (not including heart or lung transplant),12,13 pre-
or post-heart transplant,14 pre- or post-lung transplant,15-18 cardiogenic
shock/circulatory failure (outside of the context of cardiac surgery),
respiratory failure and severe lung disease (not including lung
transplantation),19-21 trauma/hypothermia/drowning,22 and miscellaneous.
The classification process was done using a hierarchical system of diag-
nosis and procedure code criteria (Appendix Table E1) to create mutually
exclusive groups. After initial examination, 2 groups were excluded from
further analysis. The trauma/hypothermia/drowning group had an insuffi-
cient volume of admission records (no year with>7 admissions nation-
wide) to be analytically useful. The miscellaneous group (those who had
a recorded ECMO procedure code but none of the related diagnosis or pro-
cedure codes that would help identify the indication for ECMO) was re-
viewed in detail. The primary diagnosis and procedure codes present in
these records revealed no plausible indication for ECMO. The mortality
rates and length of hospital stay recorded in these records was not consis-
tent with ECMO use. Therefore, it was thought that this group likely rep-
resented the fraction of records in which an ECMO procedure code was
entered erroneously. This process left 5 remaining groups for analysis,
hereafter referred to by the following abbreviated labels: post-
cardiotomy, heart transplant, lung transplant, cardiogenic shock, and respi-
ratory failure.
Discharge weights were used to create national estimates for the use of
ECMO within the NIS stratified sampling frame, and ECMO use was
analyzed by group and year. Primary outcome measures included inpatient
length of stay (variable LOS), total inpatient hospital charges (variable
TOTCHG), calculated mean hospital charges per day, and in-hospital mor-
tality (variable DIED). Discharge disposition (for patients discharged alive)
was defined using the variable DISPUNIFORM as discharge to home,
transfer to another acute-care hospital, or discharge to rehabilitation
(including skilled nursing facility, long-term subacute care hospital, or
home-based nursing care), and then summarized as discharge to home or
nonhome.The Journal of Thoracic and CaHospital charges and charges per day were indexed to inflation by ad-
justing all values to 2009 dollars using the Bureau of Labor Statistics Con-
sumer Price Index (CPI). The CPI subindex specific to inpatient hospital
services was used with a baseline of December 1996 taken as 100, and
yearly CPI values were used to generate a conversion factor to 2009 dol-
lars.23 For example, the CPI for inpatient hospital services in 2000 is
113.8; in 2009, it is 203.54. Therefore, the conversion from 2000 dollars
to 2009 dollars involves multiplying by (203.564O 113.8), or 1.78879.
Statistical Analysis
Because the stratified sampling frame of the NIS requires the use of
advanced techniques (facilitated by PROC SURVEYMEANS in SAS;
SAS Institute Inc, Cary, NC) to estimate variance, continuous variables
are presented as mean standard error. Multi-group comparisons were car-
ried out using a 1-way analysis of variance for continuous variables and
Pearson’s chi-square test for categoric variables. Trends over time were
examined using a Mann–Kendall test for trend24 (a nonparametric test to
determine the presence and direction of a trend over time). A predeter-
mined alpha of 0.05 was used as the threshold of statistical significance.
Analyses were performed using SAS 9.3.RESULTS
Overall, a total of 9243 admissions included ECMO
intervention during the study period. After exclusion of
the trauma/drowning (n ¼ 132) and miscellaneous
(n ¼ 357) groups, 8753 admissions remained for analysis.
Figure 1 shows the temporal trend in cumulative national
hospital charges for ECMO admissions, which increased
significantly from $109.0 million in 1998 to $764.7 million
in 2009 (test for trend P ¼ .0016). Figure 2 shows the trend
in number of ECMO admissions, which demonstrated a
nonsignificant increase over the study period (test for trend,
P ¼ .19) from 742 in 1998 to 1621 in 2009.
In the entire study group, average length of stay was 18.3
 1.3 days. Mean total charges were $344,009  $30,707,
with average charges per day of $40,588  $3099. Figure 3
shows the temporal trends in mean total hospital charges
and mean length of stay, both of which increased signifi-
cantly over the study period (test for trend P ¼ .0032 and
.0321, respectively). In-hospital mortality increased over
the study period from 33.1% in 1998 to 52.9% in 2009,
but this trend did not reach statistical significance (P¼ .19).
Table 1 displays the size, baseline characteristics, and
outcome variables of each group. Of note, the post-
cardiotomy group was older, with a greater male predomi-
nance, and included the greatest proportion of admissions
from a nonteaching hospital. This group had the shortest
length of stay and lowest total charges. Compared with
the post-cardiotomy group, the cardiogenic shock, respira-
tory failure, and lung transplant groups had longer lengths
of stay, higher total charges, higher rates of in-hospital mor-
tality, and higher proportions of patients with a nonhome
discharge disposition.
Figure 4 shows the temporal trends in relative frequency
of ECMO use by group over the study period. Over the
study period, a shift in case mix was observed, with a rela-
tive decrease in the post-cardiotomy group and increases inrdiovascular Surgery c Volume 148, Number 2 417
FIGURE 1. Cumulative national hospital charges (in millions of inflation-adjusted 2009 dollars) for ECMO admissions increased over the study period
(test for trend P ¼ .0016).
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plant groups.
DISCUSSION
The principal finding of this study is that a dramatic in-
crease in the total resource use associated with ECMO
use was observed over the study period. However, the
causes of this increase appear to be multifactorial. ECMO
is being used in a greater absolute number of admissions,
but this increasing trend was not statistically significant.
The significant increase in total hospital charges for
ECMO admissions was largely due to the use of ECMO
in admissions that demonstrated trends of statistically sig-
nificant increases in length of stay and total hospital
charges. In addition, these increases have been associatedFIGURE 2. Overall number of ECMO admissions per year (no significant inc
oxygenation.
418 The Journal of Thoracic and Cardiovascular Surgwith a relative shift in the case-mix of ECMO use toward
patient groups with worse clinical outcomes, longer hospi-
tal length of stay, and greater hospital charges. During this
shift, in-hospital mortality in ECMO patients increased,
although this trend did not reach statistical significance.
Most notable, the balance between the 2 largest patient
groups has shifted over the study period. In 1998, the
post-cardiotomy group comprised 80% of all ECMO ad-
missions and cardiogenic shock comprised 16%; in 2009,
the balance was nearly equal (40% post-cardiotomy vs
39% cardiogenic shock).
Respiratory failure has gone from being a trivial contrib-
utor to national ECMO use (<1 in 20 ECMO admissions in
1998) to a small but growing contributor group (>1 in 8 in
2009). This trend may become even more pronounced inrease over time, test for trend P ¼ .19). ECMO, Extracorporeal membrane
ery c August 2014
FIGURE 3. Total charges per admission (A) and length of stay (B) depicted as mean (solid lines) standard error (dotted lines). Both measures increased
significantly over the study period (test for trend P ¼ .0032 and P ¼ .0321, respectively).
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respiratory failure10,25,26 and sepsis27,28 showing benefits
compared with standard care may prompt even greater
enthusiasm for these ECMO indications.
These results share some similarities with recent analyses
of ECMO use in the pediatric population. Karamlou and
colleagues29 used the Kids’ Inpatient Database, a similarly
constructed national administrative database to the NIS, and
found 6333 pediatric admissions involving ECMO within a
study period encompassing 4 years of data (an average of
1583 per year).29 Our finding of 9243 adult admissions
involving ECMO within a study period encompassing 12
years of data (770 per year) is consistent with the prior
finding that adult ECMOvolume is lower than pediatric vol-
ume.3 The overall in-hospital mortality rate in this study
(51.0%) did not differ substantially from that in the study
by Karamlou and colleagues (45.6%), although a single-TABLE 1. Characteristics and outcomes of extracorporeal membrane oxy
Post-cardiotomy Heart transplant Lung transpla
n ¼ 4493 n ¼ 214 n ¼ 563
Male 64.8% 51.2% 54.0%
White 73.4% 81.8% 80.8%
Age 60.3  0.5 47.7  2.1 50.3  1.2
Nonelective admission 51.8% 67.7% 83.1%
Hospital type
Rural 0.0% 0.0% 0.0%
Urban, nonteaching 13.7% 0.0% 0.0%
Urban, teaching 86.3% 100.0% 100.0%
Payer
Medicare 19.0% 8.3% 29.1%
Medicaid 31.3% 30.2% 14.8%
Private 41.1% 45.3% 51.3%
Self-pay/other 8.7% 16.2% 4.8%
In-hospital mortality 44.2% 41.9% 54.0%
Nonhome discharge 50.6% 48.0% 78.9%
Length of stay (d) 12.9  0.9 45.8  8.7 38.1  3.4
Total charges $273,429  $31,361 $722,123  $57,494 $702,973  $50
Charges per day $41,872  $4050 $31,967  $5385 $79,286  $14,
The Journal of Thoracic and Cainstitution retrospective study of pediatric ECMO
(n ¼ 95) observed lower in-hospital mortality (27%).30
Neither of these studies provide comparison data on
resource use trends in pediatric ECMO.
Study Limitations
Substantial limitations to this study exist as a result of
structural features of the NIS database. First, ICD-9-CM
codes do not differentiate between venoarterial or venove-
nous ECMO. Although associated diagnosis codes may be
suggestive of which type of ECMO would be required (eg,
patients with respiratory patients might be more likely to
receive venovenous ECMO, and patients post-cardiotomy
might bemore likely to receivevenoarterial ECMO), no uni-
versal assumptions can be made about which ECMO strat-
egy was used, such that this analysis is not able to
examine this potential dimension of heterogeneity withingenation admissions by group
nt Cardiogenic shock Respiratory failure
P
Overall
n ¼ 2505 n ¼ 977 n ¼ 8753
57.5% 49.8% .0002 60.0%
68.8% 67.8% .087 72.2%
48.9  0.8 41.2  1.1 <.0001 53.9  0.4
74.5% 81.3% <.0001 36.3%
<.0001
0.0% 0.2% 0.03%
9.4% 6.6% 10.0%
90.6% 93.2% 89.9%
<.0001
9.7% 3.0% 11.6%
36.8% 44.8% 36.7%
44.5% 44.9% 43.3%
9.1% 7.3% 8.4%
64.0% 49.3% <.0001 51.0%
65.8% 67.3% <.0001 58.6%
19.0  1.5 23.5  1.7 <.0001 18.3  1.3
,502 $352,559  $29,037 $421,037  $39,018 <.0001 $344,009  $30,707
499 $37,489  $2684 $26,922  $2473 <.0001 $40,588  $3099
rdiovascular Surgery c Volume 148, Number 2 419
FIGURE 4. Relative frequency of ECMO use for each group, as a fraction of all ECMO admissions: post-cardiotomy (blue line), cardiogenic shock (red
line), respiratory failure (orange line), lung transplant (purple line), and heart transplant (green line). ECMO, Extracorporeal membrane oxygenation.
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available only for the entire hospital admission, which pre-
cludes knowledge of the duration of ECMO use or timing of
weaning from ECMO. Thus, this analysis cannot differen-
tiate hospital days or charges incurred during ECMO from
the remainder of the hospitalization, so it constitutes an
analysis of resource use in admissions where ECMO is
used, but not an analysis of ECMO-specific resource use.
Third, the NIS sampling frame and data variables do change
slightly from year to year, and trend analyses using NIS data
must consider this limitation. We sought to mitigate this ef-
fect by ensuring that ICD-9 code definitions for ECMO did
not change during the study period (39.65 was in use from
1988 onward; 39.66 was in use from 1990 onward) and by
designing the study period such that it did not cross the
greatest revision in the NIS data structure, which occurred
in 1998. Also, we adjusted hospital charges using the inpa-
tient hospital services subindex of the CPI to minimize the
contributions of inflation and broader increases in health
care expenditures to the observed increases in ECMO-
related resource use.
Fourth, total hospital charges as reported in the NIS
represent hospital billing, not actual expenditures or reim-
bursement. The complex, nonlinear relationships among
hospital charges, hospital costs, insurance reimbursement,
and patient co-payments complicate the extrapolation of
these results to an estimation of the true societal cost for
ECMO. In addition, the structure of the NIS as an
admissions-based database results in the potential that total
charges are underestimated. In the subset of patients whose
discharge disposition was transfer to another acute-care fa-
cility, some of these discharges may represent transfer to
another institution with a higher level of care during the
ECMO run. In this instance, total charges could be split be-
tween 2 admission records or may not be captured if the
receiving institution does not participate in the 20%420 The Journal of Thoracic and Cardiovascular Surgstratified sampling frame of the NIS. This limitation primar-
ily affects the accuracy of an analysis of the absolute magni-
tude of resource use; it would be expected to be less
significant when viewed from the perspective of analyzing
relative shifts and trends over time. However, to the degree
that the relationship among charges, costs, and other param-
eters does not change drastically over short periods of time,
hospital charges at minimum are useful for analysis of
resource use trends, allow for aggregation of data at the na-
tional level, and give some sense of the magnitude of
resource use devoted to this therapy. Many prior investiga-
tions have established a precedent for this analytic approach
in the face of these limitations.31-35CONCLUSIONS
Despite these limitations, this analysis is useful in
demonstrating the relative trends in ECMO use and their
resource use implications. These results have practice and
policy implications at the institutional, state, and national
levels, particularly in the face of increasing pressure for
complex medical interventions to demonstrate comparative
effectiveness and value, and for systems to restrain the
growth of health care expenditures. As ECMO use as a sup-
port therapy for critically ill adults continues to expand, a
more thorough understanding of its effectiveness, costs,
and demands on healthcare resources is needed. These re-
sults also will inform further studies, including more
ECMO group-specific cost-effectiveness analyses,9 to
refine our application of these findings to broader discus-
sions about health care resource use.References
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APPENDIX TABLE E1. Diagnosis and procedure code-based criteria to define extracorporeal membrane oxygenation groups
Group Code type Code Description Related criteria
Post-cardiotomy ICD-9-CM Vol 3 (Procedure) 35.x Operations on valves and septa of heart Absence of heart or lung transplant
procedure codes
ICD-9-CM Vol 3 (Procedure) 36.x Operations on vessels of heart
ICD-9-CM Vol 3 (Procedure) 37.1 Cardiotomy and pericardiotomy
ICD-9-CM Vol 3 (Procedure) 37.3x Pericardiectomy and excision of lesion of
heart
ICD-9-CM Vol 3 (Procedure) 441.x Major aortic dissection or aneurysm
repair
Heart transplant ICD-9-CM Vol 3 (Procedure) 37.51 Heart transplantation Absence of lung transplant procedure
codes
Lung transplant ICD-9-CM Vol 3 (Procedure) 33.5 Lung transplantation Absence of heart transplant procedure
code
ICD-9-CM Vol 3 (Procedure) 33.6 Heart-lung transplantation
Cardiogenic shock CCS diagnoses 107 Cardiac arrest and ventricular fibrillation Absence of cardiac surgical, heart, or
lung transplant procedure codes
CCS diagnoses 108 Congestive heart failure; nonhypertensive
CCS diagnoses 100 Acute myocardial infarction
CCS diagnoses 97 Pericarditis, endocarditis, and
myocarditis; cardiomyopathy
CCS diagnoses 106 Cardiac dysrhythmias
CCS diagnoses 101 Coronary atherosclerosis and other heart
disease
CCS diagnoses 103 Pulmonary heart disease
Respiratory failure CCS diagnoses 131 Respiratory failure, insufficiency, or
arrest (adult)
Absence of cardiac surgical, heart, or
lung transplant procedure codes
CCS diagnoses 122 Pneumonia
CCS diagnoses 123 Influenza
CCS diagnoses 130 Pneumothorax or pulmonary collapse
CCS diagnoses 132 Lung disease due to external agents
CCS diagnoses 126 Other upper respiratory infections
CCS diagnoses 3 Bacterial infection
Trauma/drowning CCS diagnoses 2601-2615 ICD-9-CM E-codes for trauma and
drowning
Absence of cardiac surgical, heart, or
lung transplant procedure codes
Absence of diagnosis codes for
respiratory failure or cardiogenic
shock
Miscellaneous Absence of codes to qualify for any of 6
above groups
CCS, Clinical Classifications Software; ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification.
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